Tag: Fat pad atrophy

Over 2 million people worldwide have been prescribed semaglutide, and a surprising side effect gaining attention on social media is “Wegovy feet”. This non-medical term describes the foot pain and cosmetic changes that can arise from the rapid weight loss facilitated by GLP-1 agonist medications like Wegovy.

While Ozempic (semaglutide) is widely known for its effects on blood sugar regulation and significant weight loss, a lesser-discussed phenomenon, colloquially termed "Ozempic feet," can cause noticeable changes in foot structure and comfort. This can result in the loss of crucial fat padding that provides natural shock absorption, leading to discomfort and other foot-related issues.